Trial Profile
Protocol to evaluate quality of life in patients with peripheral arterial disease in the UK who have been prescribed cilostazol (Pletal) as part of their clinical management plan
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Jun 2006
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Embolism and thrombosis; Peripheral arterial disorders
- Focus Therapeutic Use
- 01 Jun 2006 New trial record.